{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:46:24Z","timestamp":1792183584745,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jcv.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T05:33:24Z","timestamp":1486445604000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Highlights from the 2016 HIV diagnostics conference: The new landscape of HIV testing in laboratories, public health programs and clinical practice"],"prefix":"10.1016","volume":"91","author":[{"given":"Laura G.","family":"Wesolowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Michele","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcv.2017.01.009_bib0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Insight Start Study Group","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2017.01.009_bib0010","article-title":"Updated HIV testing terminology and technology","author":"Owen","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0015","article-title":"Evaluating HIV test performance","author":"Branson","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0020","article-title":"Why HIV tests are regulated as they are and understanding the package insert","author":"Akolkar","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0025","series-title":"Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations","author":"Centers for Disease Control and Prevention and Association of Public Health Laboratories","year":"2014"},{"key":"10.1016\/j.jcv.2017.01.009_bib0030","article-title":"The new landscape of HIV testing","author":"Parker","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0035","article-title":"Evaluation of newly approved HIV antigen-antibody tests individually and when used in the CDC\/APHL HIV diagnostic algorithm","author":"Delaney","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0040","article-title":"Efficacy of 4th generation HIV screening algorithm in detecting acute HIV infection and the utility of Abbott Architect signal-to-cutoff ratio in that regard","author":"Pasalar","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0045","article-title":"Overcoming the challenges and barriers to implementing the HIV diagnostic testing algorithm in your laboratory","author":"Pentella","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0050","article-title":"Implementation of 4th generation HIV testing algorithm at a public health STD clinic for real-time screening and confirmation","author":"Gradus","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0055","article-title":"APHL\/CDC project for referral of HIV nucleic acid amplification testing (NAT) for US public health laboratories","author":"Gaynor","year":"2016","journal-title":"HIV Diagnostics Conference"},{"issue":"1","key":"10.1016\/j.jcv.2017.01.009_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11904-014-0251-7","article-title":"HIV testing updates and challenges: when regulatory caution and public health imperatives collide","volume":"12","author":"Branson","year":"2015","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.jcv.2017.01.009_bib0065","article-title":"New technology and its impact on the CDC\/APHL laboratory testing algorithm","author":"Wesolowski","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0070","article-title":"Performance evaluation of two recently FDA-Approved Ag\/Ab combo assays in early HIV-1 infections","author":"Masciotra","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0075","article-title":"Performance evaluation of HIV supplemental assays","author":"Luo","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0080","unstructured":"Bio-Rad Laboratories. Geenius HIV 1\/2 Supplemental Assay. 2014; http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/PremarketApprovalsPMAs\/UCM420735.pdf."},{"key":"10.1016\/j.jcv.2017.01.009_bib0085","article-title":"Comparative performance of the Geenius HIV-1\/HIV-2 Supplemental Test in florida\u2019s public health testing population","author":"Bennett","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0090","article-title":"Diagnosis of HIV-2 infection by an HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform","author":"Chang","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0095","article-title":"Sensitive detection and accurate quantification of HIV-2 DNA using droplet digital PCR","author":"Styer","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0100","article-title":"Is it always necessary for the ARCHITECT 4th-Generation HIV-1\/2 Ag\/Ab Combo assay to be repeatedly reactive before moving forward in the centers for disease control and prevention HIV screening algorithm?","author":"Ramos","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0105","article-title":"Performance of the Abbott Architect HIV Ag\/Ab Combo assay in the US army HIV diagnostic algorithm","author":"Manak","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0110","article-title":"Uses of HIV laboratory data in surveillance, and challenges with reporting","author":"Barskey","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0115","article-title":"Use of lab data for prevention","author":"McNaghten","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0120","article-title":"Challenges and success of implementing the HIV diagnostic testing algorithm: reports from four HIV surveillance programs","author":"Anderson","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0125","article-title":"Promoting the recommended HIV diagnostic algorithm: practical information for laboratories","author":"Russell","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0130","article-title":"Health department HIV testing programs: status and opportunities","author":"Randall","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0135","article-title":"Perceptions and performance of self-administered rapid HIV tests conducted by untrained users in real world settings","author":"Chavez","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0140","article-title":"Evaluation of new HIV testing technologies in a clinical setting with high incidence: rationale, study design and preliminary results from project DETECT","author":"Delaney","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0145","article-title":"Performance evaluation of the INSTI HIV-1\/2 antibody point-of-care test in early and established infections","author":"Adams","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0150","article-title":"Rapid HIV testing, New Jersey, 2007\u20132014","author":"Mohammed","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0155","article-title":"Improving the impact of HIV testing through better linkage and more timely viral suppression","author":"Delaney","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0160","article-title":"Evolving state laboratory diagnostic capacity during an HIV outbreak","author":"Blosser","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0165","article-title":"Beyond drug resistance testing: using HIV-1 sequence data to infer transmission networks and inform public health action","author":"Oster","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0170","article-title":"Absence of serological response following early treatment of acute HIV infection","author":"Manak","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0175","article-title":"HIV antibodies as markers of HIV systemic reservoir and viral suppression","author":"Keating","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0180","article-title":"Dried blood spots (DBS) may have high utility both in resource limited settings and in hard to reach populations for diagnosis and treatment decisions","author":"Mei","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0185","first-page":"2015","article-title":"Evaluation of an emergency department HIV and syphilis screening program using rapid point of care diagnostics in Detroit, Michigan","author":"Ham","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0190","article-title":"Multiplex screening assays\u2013advancing targeted screening of co-morbidity via DPP\u00aeHIV-syphilis multiplex rapid test","author":"Ippolito","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0195","article-title":"Performance of a rapid, 60s multiplex test for simultaneous detection of antibodies to HIV-1, HIV-2 and T. pallidum in serum, plasma and whole blood","author":"Galli","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0200","article-title":"The effects of MDRI updates and transition to a new recency assay on HIV incidence estimation in the United States","author":"Hernandez","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0205","article-title":"Luminex-based multiplex assay for HIV incidence","author":"Yufenyuy","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0210","article-title":"Use of the VioOne HIV Profile for detection of recent HIV-1 infection","author":"Chetty","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0215","article-title":"A generalizable method with improved accuracy for estimation of HIV infection duration using clinical HIV testing histories","author":"Pilcher","year":"2016","journal-title":"HIV Diagnostics Conference"},{"key":"10.1016\/j.jcv.2017.01.009_bib0220","article-title":"Unmodified diagnostic assay provides similar performance to avidity modification for surveillance and clinical recency staging applications","author":"Grebe","year":"2016","journal-title":"HIV Diagnostics Conference"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217300240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217300240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T13:52:25Z","timestamp":1536069145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653217300240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":44,"alternative-id":["S1386653217300240"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2017.01.009","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highlights from the 2016 HIV diagnostics conference: The new landscape of HIV testing in laboratories, public health programs and clinical practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}